SCHEMBL25351968

SCHEMBL25351968

COC(=O)c1c[nH]c(Cc2ccc(Br)cn2)c1

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NR4A2 P43354 1/20 0.39
MMP2 P08253 1/20 0.36
MMP9 P14780 1/20 0.36
MMP8 P22894 1/20 0.36
MMP13 P45452 1/20 0.36
ALDH1A1 P00352 3/20 0.36
KDM4E B2RXH2 2/20 0.36
LMNA P02545 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
MAPK1 P28482 1/20 0.35
BAZ2B Q9UIF8 1/20 0.35
BAZ2A Q9UIF9 1/20 0.35
TSHR P16473 1/20 0.35
HTT P42858 1/20 0.35
POLB P06746 1/20 0.34
CDK8 P49336 1/20 0.34
RECQL P46063 1/20 0.34
GPR84 Q9NQS5 1/20 0.34
NEK1 Q96PY6 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25352502 0.86 CA12 (0.41) ALDH1A1KDM4ELMNAMAPK1BAZ2B
SCHEMBL25349230 0.78 ACACB (0.38)
SCHEMBL25354279 0.78 LIMK1 (0.35) ALDH1A1
SCHEMBL25353123 0.75 HRH3 (0.44) ALDH1A1
SCHEMBL7373231 0.72 ALDH1A1 (0.46) ALDH1A1KDM4ELMNABAZ2BBAZ2A
SCHEMBL31565403 0.71 MAPK1 (0.42) ALDH1A1KDM4ELMNASMN1; SMN2MAPK1
SCHEMBL25351359 0.70 MAP2K1 (0.42) ALDH1A1KDM4ELMNATSHRHTT
SCHEMBL25353032 0.70 AGBL2 (0.36) ALDH1A1LMNASMN1; SMN2BAZ2BBAZ2A
SCHEMBL21802602 0.69 MAP2K1 (0.41) ALDH1A1KDM4ELMNASMN1; SMN2HTT
SCHEMBL25351734 0.69 CA12 (0.36) ALDH1A1KDM4ELMNAMAPK1BAZ2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4479138-A1 INHIBITORS OF RNA HELICASE DHX9 AND USES THEREOF Accent Therapeutics, Inc. (US) 2024-12-25 EP disclosed
WO-2023154519-A1 INHIBITORS OF RNA HELICASE DHX9 AND USES THEREOF ACCENT THERAPEUTICS, INC. (US) 2023-08-17 WO disclosed